Reduction of Breast Enlargement Using the Da Vinci Xi Robot (NCT04597515) | Clinical Trial Compass
UnknownNot Applicable
Reduction of Breast Enlargement Using the Da Vinci Xi Robot
France5 participantsStarted 2020-11-01
Plain-language summary
Breast enlargement reductions are frequent interventions. One of the main issue associated with this surgery remains the ransom scar, wide at the periareolar level, vertical at the subareolar level and in the submammary groove.
The expected result is to achieve a reduction in breast enlargement with no visible scar using Da Da Vinci Xi robot.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women over the age of 18
* Category 1 or 2 according to the classification of Regnault
* Breast size cup c or more
* Areola "looking in front", ie a distance between point A (at noon at the top of the areola) at the mid-sternal point of about 16 cm to 24 cm
* Ptosis (distance between the lowest part of the breast and the furrow under the breast) to a maximum of 7cm (measurement in sitting position)
* Expected correction of ptosis by half with reduction of 1 to 3 cup sizes
* Good quality thick skin
* Affiliated patient or beneficiary of a social security scheme
* Patient requesting breast reduction
* Patient who signed free and informed consent
Exclusion Criteria:
* Areola "look down"; point A more than 25 cm
* Ptose greater than and equal to 8 cm
* Thin skin
* Smoker
* Patient on anti-coagulant
* Patient participating in another clinical study
* Protected patient: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision;
* Pregnant, lactating woman